| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $424.8M | $415.9M | $425.2M |
| YoY Revenue Growth % | +2.2% | -2.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$159.9M | -$36.4M | -$76.4M |
| Operating Margin % | -37.6% | -8.7% | -18.0% |
| Net Income (GAAP) | -$222.0M | -$83.1M | -$99.5M |
| EBITDA (Normalized) | -$139.3M | $15.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $85.5M | $64.6M | $43.8M |
| Capital Expenditures (CapEx) | $25.7M | $65.0M | — |
| Free Cash Flow (FCF) | $59.9M | -$418.0K | $43.8M |
| FCF Margin % | 14.1% | -0.1% | 10.3% |
| Return on Invested Capital (ROIC %) | -20.0% | -3.2% | — |
| Cash & Short-Term Equivalents | $155.6M | $89.5M | — |
| Total Debt (Short + Long Term) | $226.7M | $265.3M | — |
| Total Stockholders' Equity | $559.4M | $713.3M | — |